Bristol Myers Squibb Co Drug Patent Portfolio

Bristol Myers Squibb Co's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb Co News

Korean biosimilars prepare for a surge of major patent expirations

25 Feb, 2026

Major pharmaceuticals are set to encounter a significant patent expiration wave in 2026 | Drug Discovery News

24 Feb, 2026

Is it a good time to invest in Bristol Myers Squibb after a 25% decline? | The Motley Fool

21 Feb, 2026

Is it a good time to invest in Bristol Myers Squibb after a 25% decline? - The Globe and Mail

21 Feb, 2026

See More